Cybin (CYBN) - Cash Funds Calculated per Share

Corporate emblem and logo of Cybin Inc (CYBN)

Strict FDA oversight and the patent protection of Cybin Inc. (CYBN) contrast with the rigorous control of biosample transportation. The cash-per-share valuation helps balance these factors, with the parameter stabilizing at 1.68. The company's current strategy relies on securing a major pharmaceutical partner to co-fund the subsequent stages of clinical trials.

cybin.com - CYBN Cash per Single Share (period 07/04/2022 - 01/05/2026)

Analytical breakdowns for Cybin Inc.

- stock quotes and analyst forecast:
- cash position and cash flow details:
Summary company analysis:CYBN Cybin Corp
Manufactured product of cybin.com

Cash per share dynamics reflect the ability of Cybin Inc. (CYBN) to fund psychedelic development in the absence of revenue and amid a dependence on external capital injections. This metric is calculated by dividing total liquid assets by the number of shares outstanding, measuring the actual cash reserve per share, which allows investors to assess the capital runway before the next issuance round.